Abstract
Purpose:
Subacute thyroiditis (SAT) is a transient inflammatory disorder of the thyroid gland with a possible viral etiology. We conducted this study to estimate the pooled prevalence of thyroid autoantibodies in SAT patients. This question arose due to the varying reports on the positivity rates of thyroid autoantibodies among SAT patients.
Methods:
We searched PubMed, Embase, Scopus, and Web of Science from their inception until March 25th, 2023. Observational studies reporting the positivity rate of thyroid autoantibodies for more than ten patients were included. We used the Joanna Briggs Institute’s (JBI) critical appraisal checklist to assess the quality of the included studies. Pooled prevalence estimates with 95% confidence intervals were calculated using the random effects model. Subgroup analyses were performed to find sources of heterogeneity.
Results:
Out of 1373 identified records, 32 studies involving 2348 SAT patients were included in our study. Thyroglobulin antibody (TgAb) and thyroid peroxidase antibody (TPOAb) were positive in 22.8% and 12.2% of patients, respectively. The Study design, mean erythrocyte sedimentation rate and mean thyroid-stimulating hormone of patients were identified as sources of heterogeneity. As our secondary objectives, we found a recurrence rate of 14.7% and permanent hypothyroidism in 11.6% of patients.
Conclusion:
The results of our study revealed a low TPOAb positivity rate in SAT patients, consistent with its non-autoimmune etiology. The TgAb positivity rate in SAT patients was higher than that of the general population, possibly explained by the transient release of thyroglobulin into the bloodstream during the thyrotoxic phase, leading to subsequent TgAb production. Furthermore, our findings demonstrate a notable recurrence rate and permanent hypothyroidism among SAT patients, highlighting the importance of ongoing follow-up care.
Similar content being viewed by others
References
M. Popescu, A. Ghemigian, C.M. Vasile, A. Costache, M. Carsote, A.E. Ghenea, The new entity of subacute thyroiditis amid the COVID-19 pandemic: from infection to vaccine. Diagnostics (Basel) 12, 960 (2022). https://doi.org/10.3390/diagnostics12040960
N. Erdem, M. Erdogan, M. Ozbek, M. Karadeniz, S. Cetinkalp, A.G. Ozgen, F. Saygili, C. Yilmaz, M. Tuzun, T. Kabalak, Demographic and clinical features of patients with subacute thyroiditis: results of 169 patients from a single university center in Turkey. J. Endocrinol. Invest. 30, 546–550 (2007). https://doi.org/10.1007/BF03346347
V. Fatourechi, J.P. Aniszewski, G.Z.E. Fatourechi, E.J. Atkinson, S.J. Jacobsen, Clinical features and outcome of subacute thyroiditis in an incidence cohort: Olmsted County, Minnesota, study. J. Clin. Endocrinol. Metab. 88, 2100–2105 (2003). https://doi.org/10.1210/jc.2002-021799
P. He, H. Yang, Q. Lai, Y. Kuang, Z. Huang, X. Liang, H. Huang, Y. Qin, Z. Luo, The diagnostic value of blood cell-derived indexes in subacute thyroiditis patients with thyrotoxicosis: a retrospective study. Ann. Transl. Med. 10, 322 (2022). https://doi.org/10.21037/atm-22-719
J. Görges, J. Ulrich, C. Keck, D. Müller-Wieland, S. Diederich, O.E. Janssen, Long-term outcome of subacute thyroiditis. Exp. Clin. Endocrinol Diabetes 128, 703–708 (2020). https://doi.org/10.1055/a-0998-8035
J. Zhang, G. Ding, J. Li, X. Li, L. Ding, X. Li, S. Yang, F. Tang, Risk factors for subacute thyroiditis recurrence: A systematic review and meta-analysis of cohort studies. Front Endocrinol (Lausanne) 12, 783439 (2021). https://doi.org/10.3389/fendo.2021.783439
S.N. Dwivedi, T. Kalaria, H. Buch, Thyroid autoantibodies. J. Clin. Pathol 76, 19–28 (2023). https://doi.org/10.1136/jcp-2022-208290
J. Klubo-Gwiezdzinska, L. Wartofsky, Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol. Arch. Intern. Med. 132, 16222 (2022). https://doi.org/10.20452/pamw.16222
F. Bogazzi, L. Bartalena, S. Brogioni, A. Burelli, L. Manetti, M.L. Tanda, M. Gasperi, E. Martino, Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography. Eur. J. Endocrinol 140, 452–456 (1999). https://doi.org/10.1530/eje.0.1400452
M.E. Sencar, M. Calapkulu, D. Sakiz, S. Hepsen, A. Kus, P. Akhanli, I.O. Unsal, M. Kizilgul, B. Ucan, M. Ozbek, E. Cakal, An evaluation of the results of the steroid and non-steroidal anti-inflammatory drug treatments in subacute thyroiditis in relation to persistent hypothyroidism and recurrence. Sci. Rep. 9, 16899 (2019). https://doi.org/10.1038/s41598-019-53475-w
N. Omori, K. Omori, K. Takano, Association of the ultrasonographic findings of subacute thyroiditis with thyroid pain and laboratory findings. Endocr. J. 55, 583–588 (2008). https://doi.org/10.1507/endocrj.k07e-163
J. Sato, T. Uchida, K. Komiya, H. Goto, K. Takeno, R. Suzuki, A. Honda, M. Himuro, H. Watada, Comparison of the therapeutic effects of prednisolone and nonsteroidal anti-inflammatory drugs in patients with subacute thyroiditis. Endocrine 55, 209–214 (2017). https://doi.org/10.1007/s12020-016-1122-3
E. Nishihara, N. Amino, T. Kudo, K. Kohsaka, M. Ito, S. Fukata, M. Nishikawa, H. Nakamura, A. Miyauchi, Moderate frequency of anti-thyroglobulin antibodies in the early phase of subacute thyroiditis. Eur. Thyroid. J. 8, 268–272 (2019). https://doi.org/10.1159/000501033
Ç.T. Bahadir, M. Yilmaz, E. Kiliçkan, Factors affecting recurrence in subacute granulomatous thyroiditis. Arch. Endocrinol. Metab. 66, 286–294 (2022). https://doi.org/10.20945/2359-3997000000473
D. Fadime, Cut off value of technetium uptake in the differential diagnosis of Graves, disease and subacute thyroiditis. Asia Ocean J. Nucl. Med. Biol. 8, 54–57 (2020). https://doi.org/10.22038/aojnmb.2019.14241
M.A. Hasanat, M.A. Rumi, M.N. Alam, K.N. Hasan, M. Salimullah, M.A. Salam, M. Fariduddin, H. Mahtab, A.K. Khan, Status of antithyroid antibodies in Bangladesh. Postgrad. Med. J. 76, 345–349 (2000). https://doi.org/10.1136/pmj.76.896.345
M.J. Page, J.E. McKenzie, P.M. Bossuyt, I. Boutron, T.C. Hoffmann, C.D. Mulrow, L. Shamseer, J.M. Tetzlaff, E.A. Akl, S.E. Brennan, R. Chou, J. Glanville, J.M. Grimshaw, A. Hróbjartsson, M.M. Lalu, T. Li, E.W. Loder, E. Mayo-Wilson, S. McDonald, L.A. McGuinness, L.A. Stewart, J. Thomas, A.C. Tricco, V.A. Welch, P. Whiting, D. Moher, The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372, n71 (2021). https://doi.org/10.1136/bmj.n71
Z. Munn, S. Moola, K. Lisy, D. Riitano, C. Tufanaru, Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. Int. J. Evid. Based Healthc 13, 147–153 (2015). https://doi.org/10.1097/XEB.0000000000000054
C.B. Begg, M. Mazumdar, Operating characteristics of a rank correlation test for publication bias. Biometrics 50, 1088–1101 (1994)
M. Egger, G. Davey Smith, M. Schneider, C. Minder, Bias in meta-analysis detected by a simple, graphical test. BMJ 315, 629–634 (1997). https://doi.org/10.1136/bmj.315.7109.629
S. Duval, R. Tweedie, Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56, 455–463 (2000). https://doi.org/10.1111/j.0006-341x.2000.00455.x
J.G. Hollowell, N.W. Staehling, W.D. Flanders, W.H. Hannon, E.W. Gunter, C.A. Spencer, L.E. Braverman, Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol Metab. 87, 489–499 (2002). https://doi.org/10.1210/jcem.87.2.8182
A. Amouzegar, S. Gharibzadeh, E. Kazemian, L. Mehran, M. Tohidi, F. Azizi, The prevalence, incidence and natural course of positive antithyroperoxidase antibodies in a population-based study: Tehran Thyroid Study. PLoS One 12, e0169283 (2017). https://doi.org/10.1371/journal.pone.0169283
M.P. Baruah, B. Bhattacharya, U.M. Baruah, C-Reactive Protein Level can be a Better Indicator than Erythrocyte Sedimentation Rate in Assessing the Severity of Inflammation and Guiding Glucocorticoid Therapy in Subacute Thyroiditis. Indian J. Endocrinol Metab. 26, 328–333 (2022). https://doi.org/10.4103/ijem.ijem_229_22
A. Brancatella, N. Viola, G. Rutigliano, D. Sgrò, F. Santini, F. Latrofa, Subacute Thyroiditis during the SARS-CoV-2 pandemic. J. Endocr. Soc. 5, bvab130 (2021). https://doi.org/10.1210/jendso/bvab130
K. Luotola, P. Mantula, J. Salmi, A.M. Haapala, P. Laippala, M. Hurme, Allele 2 of interleukin-1 receptor antagonist gene increases the risk of thyroid peroxidase antibodies in subacute thyroiditis. APMIS 109, 454–460 (2001). https://doi.org/10.1034/j.1600-0463.2001.090608.x
C.A. Spencer, M. Takeuchi, M. Kazarosyan, C.C. Wang, R.B. Guttler, P.A. Singer, S. Fatemi, J.S. LoPresti, J.T. Nicoloff, Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma. J. Clin. Endocrinol. Metab. 83, 1121–1127 (1998). https://doi.org/10.1210/jcem.83.4.4683
Y. Li, D. Teng, Z. Shan, X. Teng, H. Guan, X. Yu, C. Fan, W. Chong, F. Yang, H. Dai, X. Gu, Y. Yu, J. Mao, D. Zhao, J. Li, Y. Chen, R. Yang, C. Li, W. Teng, Antithyroperoxidase and antithyroglobulin antibodies in a five-year follow-up survey of populations with different iodine intakes. J. Clin. Endocrinol. Metab. 93, 1751–1757 (2008). https://doi.org/10.1210/jc.2007-2368
D. Ricci, A. Brancatella, M. Marinò, M. Rotondi, L. Chiovato, P. Vitti, F. Latrofa, The detection of serum IgMs to thyroglobulin in subacute thyroiditis suggests a protective role of IgMs in thyroid autoimmunity. J. Clin. Endocrinol Metab. 105, dgaa038 (2020). https://doi.org/10.1210/clinem/dgaa038
R. Volpé, V.V. Row, C. Ezrin, Circulating viral and thyroid antibodies in subacute thyroiditis. J. Clin. Endocrinol Metab. 27, 1275–1284 (1967). https://doi.org/10.1210/jcem-27-9-1275
A. Kotwal, M. Stan, Thyrotropin receptor antibodies-an overview. Ophthalmic Plast Reconstr. Surg. 34, S20–S27 (2018). https://doi.org/10.1097/IOP.0000000000001052
G. Barbesino, Y. Tomer, Clinical review: Clinical utility of TSH receptor antibodies. J. Clin. Endocrinol Metab. 98, 2247–2255 (2013). https://doi.org/10.1210/jc.2012-4309
T. Diana, K.A. Ponto, G.J. Kahaly, Thyrotropin receptor antibodies and Graves’ orbitopathy. J. Endocrinol Invest. 44, 703–712 (2021). https://doi.org/10.1007/s40618-020-01380-9
M. Stasiak, B. Tymoniuk, B. Stasiak, A. Lewiński, The risk of recurrence of subacute thyroiditis is HLA-dependent. Int. J. Mol. Sci. 20, 1089 (2019). https://doi.org/10.3390/ijms20051089
D.S. Ross, H.B. Burch, D.S. Cooper, M.C. Greenlee, P. Laurberg, A.L. Maia, S.A. Rivkees, M. Samuels, J.A. Sosa, M.N. Stan, M.A. Walter, 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26, 1343–1421 (2016). https://doi.org/10.1089/thy.2016.0229
A. Saklamaz, Is there a drug effect on the development of permanent hypothyroidism in subacute thyroiditis? Acta Endocrinol (Buchar) 13, 119–123 (2017). https://doi.org/10.4183/aeb.2017.119
M. Ziaka, A. Exadaktylos, Insights into SARS-CoV-2-associated subacute thyroiditis: from infection to vaccine. Virol J. 20, 132 (2023). https://doi.org/10.1186/s12985-023-02103-1
M. Rotondi, F. Coperchini, G. Ricci, M. Denegri, L. Croce, S.T. Ngnitejeu, L. Villani, F. Magri, F. Latrofa, L. Chiovato, Detection of SARS-COV-2 receptor ACE-2 mRNA in thyroid cells: a clue for COVID-19-related subacute thyroiditis. J. Endocrinol Invest 44, 1085–1090 (2021). https://doi.org/10.1007/s40618-020-01436-w
M. Stasiak, A. Lewiński, New aspects in the pathogenesis and management of subacute thyroiditis. Rev. Endocr. Metab. Disord. 22, 1027–1039 (2021). https://doi.org/10.1007/s11154-021-09648-y
N. Viola, A. Brancatella, D. Sgrò, F. Santini, F. Latrofa, Clinical, biochemical features and functional outcome of patients with SARS-CoV-2-related subacute thyroiditis: a review. Endocrine 79, 448–454 (2023). https://doi.org/10.1007/s12020-022-03247-w
E. Meftah, R. Rahmati, F. Zari Meidani, S. Khodadadi, K. Chitzan-Zadeh, F. Esfahanian, S. Afshar, Subacute thyroiditis following COVID-19: A systematic review. Front Endocrinol (Lausanne) 14, 1126637 (2023). https://doi.org/10.3389/fendo.2023.1126637
N. Araki, M. Iida, N. Amino, S. Morita, A. Ide, E. Nishihara, M. Ito, J. Saito, T. Nishikawa, K. Katsuragi, A. Miyauchi, Rapid bioassay for detection of thyroid-stimulating antibodies using cyclic adenosine monophosphate-gated calcium channel and aequorin. Eur. Thyroid J. 4, 14–19 (2015). https://doi.org/10.1159/000371740
P.G. Espinoza, C.L. Guendelman, L.N. Quevedo Limón, R.J. Fernández, A comparison between two imaging techniques for the diagnosis of subacute thyroiditis (de Quervain thyroiditis): brief communication. Clin. Nucl. Med. 35, 862–864 (2010). https://doi.org/10.1097/RLU.0b013e3181f49adc
S. Hepsen, P. Akhanli, M.E. Sencar, H. Duger, D. Sakiz, M. Kizilgul, I. Ozturk Unsal, B. Ucan, M. Ozbek, E. Cakal, The evaluation of low- and high-dose steroid treatments in subacute thyroiditis: A retrospective observational study. Endocr Pract 27, 594–600 (2021). https://doi.org/10.1016/j.eprac.2020.11.009
K. Kamijo, K. Ishikawa, M. Tanaka, Clinical evaluation of 3rd generation assay for thyrotropin receptor antibodies: the M22-biotin-based ELISA initiated by Smith. Endocr. J. 52, 525–529 (2005). https://doi.org/10.1507/endocrj.52.525
K. Kamijo, H. Murayama, T. Uzu, K. Togashi, G.J. Kahaly, A novel bioreporter assay for thyrotropin receptor antibodies using a chimeric thyrotropin receptor (mc4) is more useful in differentiation of Graves’ disease from painless thyroiditis than conventional thyrotropin-stimulating antibody assay using porcine thyroid cells. Thyroid 20, 851–856 (2010). https://doi.org/10.1089/thy.2010.0059
S.H. Khan, A. Mahajan, B.A. Laway, R. Rasool, T.A. Rather, Technetium-99m Thyroid Scintigraphy and Human Leukocyte Antigen – B35 in Sub-Acute Thyroiditis. Indian J. Nucl. Med. 33, 306–311 (2018). https://doi.org/10.4103/ijnm.IJNM_74_18
J. Kim, H.-S. Baek, J. Ha, M.K. Kim, H.-S. Kwon, K.-H. Song, D.-J. Lim, K.-H. Baek, Differential diagnosis of thyrotoxicosis by machine learning models with laboratory findings. Diagnostics (Basel) 12, 1468 (2022). https://doi.org/10.3390/diagnostics12061468
J.I. Lee, H.W. Jang, S.K. Kim, J.Y. Choi, J.Y. Kim, K.Y. Hur, J.H. Kim, Y.-K. Min, J.H. Chung, S.W. Kim, Diagnostic value of a chimeric TSH receptor (Mc4)-based bioassay for Graves’ disease. Korean J. Intern Med. 26, 179–186 (2011). https://doi.org/10.3904/kjim.2011.26.2.179
J. Yoshimura Noh, N. Miyazaki, K. Ito, K. Takeda, S. Hiramatsu, S. Morita, A. Miyauchi, T. Murakami, K. Inomata, S. Noguchi, T. Satoh, N. Amino, Evaluation of a new rapid and fully automated electrochemiluminescence immunoassay for thyrotropin receptor autoantibodies. Thyroid 18, 1157–1164 (2008). https://doi.org/10.1089/thy.2008.0119
H. Ota, N. Amino, S. Morita, K. Kobayashi, S. Kubota, S. Fukata, N. Kamiyama, A. Miyauchi, Quantitative measurement of thyroid blood flow for differentiation of painless thyroiditis from Graves’ disease. Clin. Endocrinol (Oxf) 67, 41–45 (2007). https://doi.org/10.1111/j.1365-2265.2007.02832.x
M. Schott, D. Hermsen, M. Broecker-Preuss, M. Casati, J.C. Mas, A. Eckstein, D. Gassner, R. Golla, C. Graeber, J. van Helden, K. Inomata, J. Jarausch, J. Kratzsch, N. Miyazaki, M.A.N. Moreno, T. Murakami, H.J. Roth, W. Stock, J.Y. Noh, W.A. Scherbaum, K. Mann, Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves’ disease (GD): an international multicentre trial. Clin. Endocrinol (Oxf) 71, 566–573 (2009). https://doi.org/10.1111/j.1365-2265.2008.03512.x
M.E. Sencar, M. Çalapkulu, D. Sakiz, S. Hepsen, P. Akhanli, İ. Öztürk Ünsal, E. Çakal, Frequency of thyroid antibodies at the diagnosis of subacute thyroiditis. Turk. J. Endocrinol Metab. 24, 144–148 (2020). https://doi.org/10.25179/tjem.2020-74287
M. Stasiak, R. Michalak, B. Stasiak, A. Lewinski, Clinical characteristics of subacute thyroiditis is different than it used to be - current state based on 15 years own material. Neuro Endocrinol Lett. 39, 489–495 (2019)
N. Takasu, K. Kamijo, Y. Sato, H. Yoshimura, A. Nagata, Y. Ochi, Sensitive thyroid-stimulating antibody assay with high concentrations of polyethylene glycol for the diagnosis of Graves’ disease. Clin. Exp. Pharmacol Physiol. 31, 314–319 (2004). https://doi.org/10.1111/j.1440-1681.2004.03991.x
J.R. Wall, C.R. Strakosch, P. Bandy, R. Bayly, Nature of thyrotropin displacement activity in subacute thyroiditis. J. Clin. Endocrinol Metab. 54, 349–353 (1982). https://doi.org/10.1210/jcem-54-2-349
Y. Thewjitcharoen, K. Sirinate, B. Siriwan, N. Soontaree, H. Thep, Clinical features and outcomes of subacute thyroiditis in Thai patients. JAFES 30, 125–128 (2015). https://doi.org/10.15605/jafes.030.02.03
Y. Zhou, M. Zhou, Y. Qi, W. Wang, X. Chen, S. Wang, The prognostic value of thyroid-stimulating immunoglobulin in the management of Graves’ disease. Ther. Adv. Endocrinol Metab. 12, 20420188211044943 (2021). https://doi.org/10.1177/20420188211044943
Author contributions
A.S.: search strategy development, study selection, data extraction, quality assessment, drafting the manuscript, M.F.: search strategy development, quality assessment, statistical analysis, manuscript revision, S.M.-T.: data extraction, manuscript revision, A.Y.: study selection, manuscript revision, M.H.: study conceptualization, resolving the disagreements during the study selection, data extraction, and quality assessment processes, manuscript revision, All authors read and approved the final version of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Shekarian, A., Fakhrolmobasheri, M., Mazaheri-Tehrani, S. et al. The prevalence of positive thyroid autoantibodies in patients with subacute thyroiditis: a systematic review and meta-analysis. Endocrine 84, 29–41 (2024). https://doi.org/10.1007/s12020-023-03655-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12020-023-03655-6